全文获取类型
收费全文 | 17313篇 |
免费 | 3304篇 |
国内免费 | 305篇 |
专业分类
耳鼻咽喉 | 701篇 |
儿科学 | 441篇 |
妇产科学 | 460篇 |
基础医学 | 1233篇 |
口腔科学 | 371篇 |
临床医学 | 2235篇 |
内科学 | 4265篇 |
皮肤病学 | 794篇 |
神经病学 | 1758篇 |
特种医学 | 763篇 |
外科学 | 3649篇 |
综合类 | 58篇 |
现状与发展 | 2篇 |
预防医学 | 1214篇 |
眼科学 | 430篇 |
药学 | 649篇 |
中国医学 | 15篇 |
肿瘤学 | 1884篇 |
出版年
2024年 | 80篇 |
2023年 | 561篇 |
2022年 | 286篇 |
2021年 | 535篇 |
2020年 | 868篇 |
2019年 | 391篇 |
2018年 | 836篇 |
2017年 | 784篇 |
2016年 | 988篇 |
2015年 | 952篇 |
2014年 | 1220篇 |
2013年 | 1407篇 |
2012年 | 917篇 |
2011年 | 878篇 |
2010年 | 929篇 |
2009年 | 1134篇 |
2008年 | 795篇 |
2007年 | 648篇 |
2006年 | 764篇 |
2005年 | 657篇 |
2004年 | 556篇 |
2003年 | 469篇 |
2002年 | 394篇 |
2001年 | 214篇 |
2000年 | 136篇 |
1999年 | 218篇 |
1998年 | 317篇 |
1997年 | 320篇 |
1996年 | 361篇 |
1995年 | 320篇 |
1994年 | 204篇 |
1993年 | 153篇 |
1992年 | 140篇 |
1991年 | 146篇 |
1990年 | 79篇 |
1989年 | 131篇 |
1988年 | 104篇 |
1987年 | 81篇 |
1986年 | 88篇 |
1985年 | 92篇 |
1984年 | 88篇 |
1983年 | 72篇 |
1982年 | 77篇 |
1981年 | 53篇 |
1980年 | 55篇 |
1979年 | 34篇 |
1978年 | 49篇 |
1977年 | 48篇 |
1976年 | 32篇 |
1975年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
3.
4.
Barouyr Baroudjian Dimitri Arangalage Stefania Cuzzubbo Baptiste Hervier Celeste Lebbé Gwenael Lorillon 《Expert review of anticancer therapy》2019,19(3):209-222
Introduction: Immune checkpoint inhibitors (ICI) are now a standard of care in the treatment of many cancers leading to durable responses in patients with metastatic disease. These agents are generally well tolerated but may lead to the occurrence of immune-related adverse events (irAEs). As any organ may be affected, clinicians should be aware of the broad range of clinical manifestations and symptoms and keep in mind that toxicities may occur late, at any point along a patient’s treatment course. Although the most common irAEs are rarely severe, some of them may be associated with great morbidity and even become life-threatening. The rate of occurrence, type and severity of irAEs may vary with the type of ICI; thus, grade 3 and 4 irAEs are reported in more than 55% of patients treated with the combination of ipilimumab 3 mg/kg and nivolumab 1 mg/kg.
Area covered: This review presents the management of irAEs resulting from checkpoint blockade, with a focus on rare irAEs.
Expert commentary: With the development of immuno-oncology and the expanding role of ICI, physicians have learnt to diagnose and treat most of the irAEs that can occur. This review provides an overview of current guidelines, previously published studies and our multidisciplinary team based practices. 相似文献
5.
6.
Gian Eugenio Tontini Guido Manfredi Stefania Orlando Helmut Neumann Maurizio Vecchi Elisabetta Buscarini Luca Elli 《Digestive endoscopy》2019,31(6):627-643
Over the last decade, impressive technological advances have occurred in ultrasonography and small‐bowel endoscopy. Nowadays, endoscopic ultrasonography is an essential diagnostic tool and a therapeutic weapon for pancreatobiliary disorders. Capsule endoscopy and device‐assisted enteroscopy have quickly become the reference standard for the diagnosis of small‐bowel luminal diseases, thereby leading to radical changes in diagnostic and therapeutic pathways. We herein provide an up‐to‐date overview of the latest advances in endoscopic ultrasonography and small‐bowel endoscopy, focusing on the emerging paradigms and technological innovations that might improve clinical practice in the near future. 相似文献
7.
8.
9.
Is it possible to make a diagnosis of raw,heated, and baked egg allergy in children using cutoffs? A systematic review
下载免费PDF全文
![点击此处可从《Pediatric allergy and immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
10.
Danail Hristozov Alex Zabeo Keld Alstrup Jensen Stefania Gottardo Panagiotis Isigonis Laura Maccalman 《Nanotoxicology》2016,10(9):1215-1228
Several tools to facilitate the risk assessment and management of manufactured nanomaterials (MN) have been developed. Most of them require input data on physicochemical properties, toxicity and scenario-specific exposure information. However, such data are yet not readily available, and tools that can handle data gaps in a structured way to ensure transparent risk analysis for industrial and regulatory decision making are needed. This paper proposes such a quantitative risk prioritisation tool, based on a multi-criteria decision analysis algorithm, which combines advanced exposure and dose-response modelling to calculate margins of exposure (MoE) for a number of MN in order to rank their occupational risks. We demonstrated the tool in a number of workplace exposure scenarios (ES) involving the production and handling of nanoscale titanium dioxide, zinc oxide (ZnO), silver and multi-walled carbon nanotubes. The results of this application demonstrated that bag/bin filling, manual un/loading and dumping of large amounts of dry powders led to high emissions, which resulted in high risk associated with these ES. The ZnO MN revealed considerable hazard potential in vivo, which significantly influenced the risk prioritisation results. In order to study how variations in the input data affect our results, we performed probabilistic Monte Carlo sensitivity/uncertainty analysis, which demonstrated that the performance of the proposed model is stable against changes in the exposure and hazard input variables. 相似文献